Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Prepaid Assets: 2022-2025

Historic Prepaid Assets for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Sep 2025 value amounting to $1.5 million.

  • Orchestra BioMed Holdings' Prepaid Assets rose 19.80% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 19.80%. This contributed to the annual value of $2.1 million for FY2024, which is 64.36% up from last year.
  • As of Q3 2025, Orchestra BioMed Holdings' Prepaid Assets stood at $1.5 million, which was down 9.41% from $1.7 million recorded in Q2 2025.
  • Orchestra BioMed Holdings' Prepaid Assets' 5-year high stood at $2.3 million during Q1 2023, with a 5-year trough of $36,417 in Q2 2022.
  • In the last 3 years, Orchestra BioMed Holdings' Prepaid Assets had a median value of $1.5 million in 2023 and averaged $1.5 million.
  • Per our database at Business Quant, Orchestra BioMed Holdings' Prepaid Assets spiked by 3,931.08% in 2023 and then crashed by 48.31% in 2024.
  • Orchestra BioMed Holdings' Prepaid Assets (Quarterly) stood at $533,000 in 2022, then skyrocketed by 139.02% to $1.3 million in 2023, then surged by 64.36% to $2.1 million in 2024, then grew by 19.80% to $1.5 million in 2025.
  • Its Prepaid Assets stands at $1.5 million for Q3 2025, versus $1.7 million for Q2 2025 and $1.8 million for Q1 2025.